News
A single cell.
A global business worth billions.
A trade that can bring rewards—or human costs that cannot be measured...
Updates to South African research ethics guidelines which recognize significant potential for treating genetic diseases through heritable human genome editing...
For as long as the concept of race has existed, racial prejudice has been justified on hereditary grounds (1...
Last week, the Alabama Supreme Court called frozen embryos created via in vitro fertilization (IVF) “extrauterine children” and referred to...
SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of fog blanketing the San Francisco...
What’s next for 23andMe? Most people know the biotech company as a genetic testing service. Stories of people sending their...
How does a brain chip work?
Neuralink’s coin-size device, called N1, is designed to enable patients to carry out actions...
The discovery during the Human Genome Project in the early 2000s that we humans have only about 20,000 protein-coding genes...
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex...
With the business in a tailspin, 23andMe’s CEO assures investors there’s still plenty of money it can make on your...